ALBERTDAVD

Albert David Share Price

 

 

Start SIP in ALBERTDAVD

Start SIP

Performance

  • Low
  • ₹774
  • High
  • ₹798
  • 52 Week Low
  • ₹763
  • 52 Week High
  • ₹1,540
  • Open Price₹775
  • Previous Close₹772
  • Volume2,098

Investment Returns

  • Over 1 Month -10.19%
  • Over 3 Month -1.45%
  • Over 6 Month -1.36%
  • Over 1 Year -42.67%

Smart Investing Starts Here Start SIP with Albert David for Steady Growth!

Invest Now

Albert David Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -29.8
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 450
  • P/B Ratio
  • Average True Range
  • 19.78
  • EPS
  • 0
  • Dividend Yield
  • 0.6
  • MACD Signal
  • -8.35
  • RSI
  • 36.16
  • MFI
  • 10.74

Albert David Financials

Albert David Technicals

EMA & SMA

Current Price
₹788.00
+ 15.9 (2.06%)
pointer
  • Bearish Moving Average 13
  • Bullish Moving Average 3
  • 20 Day
  • ₹800.19
  • 50 Day
  • ₹810.54
  • 100 Day
  • ₹827.19
  • 200 Day
  • ₹886.56

Resistance and Support

776.57 Pivot Speed
  • R3 800.58
  • R2 794.07
  • R1 783.08
  • S1 765.58
  • S2 759.07
  • S3 748.08

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Albert David Ltd manufactures and markets pharmaceutical formulations, intravenous fluids, and active pharmaceutical ingredients (APIs). Serving domestic and international markets, the company provides high-quality healthcare products across therapeutic segments like anti-infectives, gastroenterology, and nutraceuticals.

Albert David has an operating revenue of Rs. 315.78 Cr. on a trailing 12-month basis. An annual revenue de-growth of -11% needs improvement, Pre-tax margin of 7% is okay, ROE of 4% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 7 which is a POOR score indicating inconsistency in earnings, a RS Rating of 38 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 41 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Albert David Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-12 Quarterly Results
2025-08-02 Quarterly Results
2025-05-13 Audited Results & Final Dividend
2025-02-12 Quarterly Results
2024-11-14 Quarterly Results
Date Purpose Remarks
2025-07-25 FINAL Rs.5.00 per share(50%)Final Dividend
2024-08-02 FINAL Rs.11.50 per share(115%)Final Dividend
2023-08-03 FINAL Rs.9.00 per share(90%)Dividend
2022-08-02 FINAL Rs.9.00 per share(90%)Dividend
2021-09-07 FINAL Rs.6.00 per share(60%)Dividend
View Albert David Dividend History Arrow

Albert David F&O

Albert David Shareholding Pattern

62.24%
0.01%
1.61%
0.6%
0.01%
27.72%
7.81%

About Albert David

  • NSE Symbol
  • ALBERTDAVD
  • BSE Symbol
  • 524075
  • Managing Director & CEO
  • Mr. Umesh Manohar Kunte
  • ISIN
  • INE155C01010

Similar Stocks to Albert David

Albert David FAQs

Albert David share price is ₹788 As on 05 December, 2025 | 10:58

The Market Cap of Albert David is ₹449.7 Cr As on 05 December, 2025 | 10:58

The P/E ratio of Albert David is -29.8 As on 05 December, 2025 | 10:58

The PB ratio of Albert David is 1.1 As on 05 December, 2025 | 10:58

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23